Get the latest delivered to your inbox
Privacy Policy

Now Reading

Teva Launches Vital Medicines Program in El Salvador for Underserved Communities

Teva Launches Vital Medicines Program in El Salvador for Underserved Communities

Published 11-27-24

Submitted by Teva Pharmaceutical

Child playing in between two people wearing masks.

Teva is pleased to announce the launch of a new program that donates vital medicines to underserved communities in El Salvador.

Working in collaboration with Americares and FUSAL, this effort aims to expand patients' access to a Healthy Future.

In El Salvador, many patients face significant barriers that prevent them from getting the treatments they need. Through this program, we are addressing critical health needs related to cardiovascular diseases, diabetes, respiratory illnesses and pain and palliative care. Our goal is to bring hope and healing to those who need it most.

This program joins seven others providing treatments to underserved populations worldwide, and we are proud to have reached our goal of launching eight access to medicines programs by 2025 ahead of schedule.

Programs like this are a testament to our commitment to Health Equity. By working closely with our partners, we deliver customized, localized solutions that truly make a difference. We invite you to read more about how we are bringing essential treatments to patients who otherwise wouldn’t have them: https://ow.ly/RvWN50SR0gp

Teva Pharmaceutical logo

Teva Pharmaceutical

Teva Pharmaceutical

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.

More from Teva Pharmaceutical

Join today and get the latest delivered to your inbox